CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.

Article Details

Citation

Boeckler F, Ohnmacht U, Lehmann T, Utz W, Hubner H, Gmeiner P

CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.

J Med Chem. 2005 Apr 7;48(7):2493-508.

PubMed ID
15801839 [ View in PubMed
]
Abstract

As an extension of a series of dopamine D(3) receptor agonists involving FAUC 54, ex-chiral pool synthesis, and biological evaluation of 3-substituted 7-aminotetrahydroindolizines was performed. Considering the structural features of both series of enantiomers, we developed a novel alignment hypothesis for D(3) agonists, allowing for the placement of the aromatic moieties on two alternative, adjacent positions. CoMFA and CoMSIA analyses yielded significant cross-validated q(2) values of 0.726 and 0.590, respectively, when a newly invented program application (IRAS) controlling the alignment selection proved to be useful. Employing the CoMFA/CoMSIA contribution maps, we were able to transform a previously constructed homology model of the D(3) receptor from an inactive into an activate state. Besides the established ionic interactions, we propose pi-stacking with Phe6.51 and a hydrogen bond between His6.55 and the acyl moiety to be primarily involved in the D(3) receptor binding of FAUC 54 and its analogues.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
PramipexoleDopamine D2 receptorKi (nM)6300N/AN/ADetails
PramipexoleDopamine D2 receptorKi (nM)21N/AN/ADetails
PramipexoleDopamine D2 receptorKi (nM)1900N/AN/ADetails
PramipexoleDopamine D3 receptorEC 50 (nM)1.5N/AN/ADetails
PramipexoleDopamine D3 receptorKi (nM)38N/AN/ADetails
PramipexoleDopamine D3 receptorKi (nM)0.88N/AN/ADetails
PramipexoleDopamine D4 receptorEC 50 (nM)15N/AN/ADetails
PramipexoleDopamine D4 receptorKi (nM)8.1N/AN/ADetails
PramipexoleDopamine D4 receptorKi (nM)130N/AN/ADetails